SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-21-009365
Filing Date
2021-04-21
Accepted
2021-04-21 16:06:03
Documents
5
Effectiveness Date
2021-04-21

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 94630
2 ex5-1.htm EX-5.1 13494
3 ex23-1.htm EX-23.1 5409
4 ex99-3.htm EX-99.3 55745
5 ex99-4.htm EX-99.4 34389
  Complete submission text file 0001493152-21-009365.txt   204765
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-255407 | Film No.: 21841499
SIC: 2834 Pharmaceutical Preparations